Where PMA Graphene Technology stands after its latest Filing
Revenue for the twelve months was $15m, down 56.8% on a year earlier, against growth of 22.8% a quarter earlier. That puts it 42 of 42 for growth among the specialty chemicals companies we cover. Free-cash-flow margin held at 4.8%. Operating margin narrowed to -37.4% from 14.7%. The diluted share count is up 9.5% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 0 of our 5 financial-health checks. Our revenue-to-maturity cash-flow model value is $0.31 a share, against a share price of $1.30.